Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.36) by 4.49 percent. This is a 142.86 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $5.420 million which beat the analyst consensus estimate of $5.270 million by 2.84 percent.